15.1 C
London
Friday, July 30, 2021
- Advertisement -

TAG

BionTech

Pfizer vaccine ‘protective for at least six months’

The effectiveness of the Pfizer vaccine wanes slightly over time but it remains strongly protective for at least six months after the second dose,...

Covid vaccine maker BioNTech reports €1.1bn profit in first quarter

German pharmaceutical company BioNTech has reported a net profit of €1.13 billion in the first quarter of this year on the back of strong...

EU agrees potential 1.8 billion-dose purchase of Pfizer vaccine

The European Union has cemented its support for Pfizer/BioNTech and its novel Covid-19 vaccine technology by agreeing to a massive contract extension for a...

Pfizer raises expectations after huge rollout of Covid-19 vaccine

Pfizer is raising its revenue expectations for the year with a huge rollout of its Covid-19 vaccine as well as strong performances from other...

Pfizer and BioNTech ask EU to clear vaccine for 12 to 15-year-olds

Pfizer and BioNTech have submitted a request for European Union drug regulators to extend the approval of the companies’ coronavirus vaccine to include children...

Europe will reach herd immunity by August – BioNTech chief

Europe can achieve herd immunity against coronavirus within the next four months, according to the head of German pharmaceutical company BioNTech. The company developed the...

Doctor and comedian among first in Lebanon to get vaccine

Lebanon has administered its first jabs of a Covid-19 vaccine. An intensive care unit physician and a well-known 93-year-old comedian became the first to receive...

Germany looking to accelerate sluggish distribution of vaccines

Chancellor Angela Merkel and German state governors were planning to talk with representatives of the pharmaceutical industry on ways to beef up the country’s...

France’s Sanofi to make Covid vaccines from rival Pfizer/BioNTech

French drug maker Sanofi has said it will help manufacture 125 million doses of the coronavirus vaccine developed by its rivals Pfizer and BioNTech,...

Poorer nations could get access to Pfizer vaccine after WHO approval

The World Health Organisation has approved the Pfizer-BioNTech coronavirus vaccine for emergency use, meaning poorer countries may soon get access to the jab already...

Latest news

- Advertisement -